Insights

Executive Q&A: How to make the annual benefits reverification process as smooth as possible for patients and key stakeholders.

Explore what is in store for the future of ambulatory pharmacy. Download the Ambulatory Pharmacy Outlook for Health Systems 2019 report to discover opportunities for health system leaders to fully leverage ambulatory pharmacy to improve revenue and enhance the patient experience.

How do nurses make a difference when it comes to patient-centric adherence programs? A Lash Group nurse shares how she offers personal support for rare disease patients.

Executive Q&A: best practices for a patient support program launch.

Lash Group's nurse educators offer empathy, experience and expertise to help patients navigate the complexities of today's specialty therapies. Learn how they add critical value to adherence programs.

The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.

How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.

An animated, immersive biosimilar market snapshot with actionable insight for manufacturers.

We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.

Innovative therapies make innovative patient services essential. Learn how Lash Group helped one manufacturer improve speed and access to therapy with an electronic provider portal for benefit verification and prior authorization.

What are the elements of innovative, effective medication adherence programs -- and how do they address the underlying causes of non-adherence?

In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?

Why do patients struggle with medication adherence even when they know it will help them? In part one of a two-part article series from Lash Group, discover how the most advanced patient support programs use behavioral science to unlock adherence.

Political advocacy can be intimidating, but it doesn’t need to be. Here are a few tips to help you get started.

Two experts in health economics and patient support team up to offer insight on how manufacturers can prepare for the impact of copay accumulators.

How adherence solutions are evolving -- with some high-tech help. Originally published on FiercePharma.com.

Phase II of DSCSA requires interoperable systems for the electronic tracking of product through the supply chain. Is pharma prepared? Learn what stakeholders need to know and do know to prepare for 2023.

Executive Q&A: The market trends and technology solutions impacting medication adherence today.

Download this new white paper from IHOC - Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies - to learn the key insights about the role HSSPs play in improving the patient experience and why patient and provider satisfaction are important data points for both payers and manufacturers to consider when deciding to include HSSPs in their networks.

Pharmacists can build stronger patient relationships, increase medication adherence and build lasting brand loyalty by initiating routine phone calls to share information. Done well, an automated outbound communication system can send messages on behalf of the pharmacist in a personal and authentic way.

Google is the first place people go when they want to find a pharmacy, so it’s absolutely vital to have a robust Google listing with up-to-date business , but having a great listing isn’t enough though. Learn what an independent pharmacy needs to do to ensure their business appears in the search results.

An integrated inventory management system can play an important role in helping specialty practices address expectations and cater to a millennial patient demographic.

Executive Q&A: How shifting coverage for some drugs from Medicare Part B to Part D could impact access and affordability for patients.

When it comes to unit dose packaging, is it time for health systems to re-evaluate how they acquire UD products? Is it more efficient to outsource or repackage in house? AHP goes beyond cost per dose to help health systems evaluate every option.

What does Medicare claims data reveal about physician-administered drugs? An Xcenda survey reveals whether physicians choose treatment based on how much they're reimbursed.

A collection of AmerisourceBergen's top insights from 2018, including commercialization considerations for novel therapies, emerging trends in retail and specialty pharmacy and best practices for managing inventory in the specialty practice.

Why is accreditation important for patient support program providers?

The high-touch, high-quality, personalized care independent pharmacies provide creates a unique value proposition in a healthcare market where more chronically ill patients need accessible care. As payers are prioritizing improved patient outcomes and a reduction in overall healthcare costs, they need to also consider new reimbursement models for these pharmacy services, a framework under which independent pharmacies are uniquely positioned to excel.

An annual influenza vaccination is the best protection against the flu virus. Some patients however, are still skeptical. Continue to educate patients on the importance of getting vaccinated. And for those that need a little extra motivation, remind them of what they could miss out on this holiday season.

Explore what is in store for the future of ambulatory pharmacy. Download the Ambulatory Pharmacy Outlook for Health Systems 2018 report to discover opportunities for health system leaders to fully leverage ambulatory pharmacy to improve revenue and enhance the patient experience.

The facts on Medicare Open Enrollment, a helpful guide for pharmacists and their patients.

What are the pitfalls of historic approaches to adherence? Learn how leading solutions combine both measurement and engagement for real results.

Open enrollment for Health Insurance Marketplace plans is here. Do PAP patients know their coverage options?

How combining the PAM survey with individual care planning can improve patient activation and adherence.

A thriving business and healthier, happier patients are a reality for independent community pharmacies who embrace the right opportunities: health and wellness, clinical care, healthcare partnerships, consumer trends and their independence.

Take our quiz to find out what superpower lies behind the white coat.

How leading patient support providers combine measurement with engagement to improve adherence.

Physician practices can leverage integrated inventory management systems to create a more user-friendly experience for patients that improves engagement, increases adherence and facilitates better outcomes.

Now is the time to encourage patients to receive an annual flu shot. Start engaging patients in a conversation about the importance of this vaccine and keep your community healthy during this flu season.

The evolving needs of the patient and historic approaches to non-adherence.

Modern inventory management systems are far more than fancy medication cabinets. They've been re-imagined for modern medicine, where complex and expensive pharmaceuticals often prove key to better outcomes at lower costs.

How can FTZs help with commercialization success? What should manufacturers consider when evaluating a FTZ and 3PL partner?

What are FTZs and why should pharma use them?

A look at how health systems can stem the tide of rising pharmacy costs with a consolidated distribution model.

Part one of the three-part series on medically integrated dispensing explores the benefits to practices and patients.

Four tips for generating more referrals from hospital-affiliated physicians.

What role does the changing healthcare coverage landscape play in support program demand and design?

Much of the complexity of the cell and gene supply chain comes from how dependent the commercialization phase is on the clinical phase. What does integration look like, and how can the right logistics partner help?

Patients face a growing number of barriers that can impede medication access and adherence. How can manufacturers help address these hurdles?

How third-party logistics (3PL) solutions can help cell and gene therapy manufacturers manage the financial aspects of launching new therapies.

The Good Neighbor Pharmacy of the Year Award recognizes a pharmacy that exemplifies what it means to be a pillar in their community. Beyond filling prescriptions, they display excellence in patient care, community outreach and innovative pharmacy practice.

As biosimilars launch, they are shaping the treatment landscape. These new options are also creating new opportunities for health system pharmacy leaders to expand their influence on patient outcomes.

Medication adherence matters for pharmacies and patients. Learn how can pharmacies connect with their non-adherent patients and keep them on their medication regimen.

An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.

An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.

By promoting health and wellness, pharmacists play a crucial role in their communities. Explore three examples of how pharmacists can positively impact the lives of the people they serve.

When it comes to diabetes care, community pharmacies have an opportunity to be the leading resource for patients.

Matt Wolf, Group Vice President, Consulting Practice, Pharmacy Healthcare Solutions shares the most common challenges the consulting teams help customers overcome.

Our experts explain how specialty pharmacy can emerge as the centerpiece of clinically-integrated, patient-centered care that minimizes obstacles and optimizes outcomes.

Claire Biermaas, Vice President of Customer Insight and Innovation, shares steps that health systems pharmacies can take today to be ready for tomorrow.

Explore the fundamentals of blockchain and how it could be used by the healthcare industry to achieve DSCSA compliance.

Learn how the right specialty pharmacy can offer value-added services for physician practices and patients.

The primary benefits of consolidated distribution, and what health systems need to know before getting started.

How manufacturers can benefit from provider-led care coordination to improve patient outcomes.

Matt Wolf, RPH, MBA, Group Vice President, Consulting Practice, Pharmacy Healthcare Solutions shares steps that health systems can take to streamline operations and improve efficiencies.

While suppliers are making fewer pre-packaged unit dose treatments available, health system pharmacies still have options for acquiring them. Learn which is best.

How do channel strategy decisions impact providers and patients—and how can you ensure a patient-centric commercialization strategy? Our strategic global sourcing experts share insights on how customers respond to channel strategy decisions.

If you’re ready to take the leap to multiple-pharmacy ownership, here are considerations to help your growing business thrive.

Our experts look at what President Trump's new plan for reducing drug prices means for manufacturers, pharmacies and the drug wholesale industry.

How health systems can gain the benefits of a centralized distribution model without the excessive capital investment.

Ambulatory pharmacies have potential for expanding the health system's role in patient care. Learn four key ways ambulatory pharmacies are driving health system success.

How is manufacturer thinking around channel strategy changing for oral oncolytics?

Can health systems implement self-distribution without the capital investment in freestanding warehouse space? Yes.

The decision to purchase a pharmacy is a big one. Once that decision is made, there are a few key steps to finding the right pharmacy and closing a deal.

Claire Biermaas, Vice President of Customer Insight and Innovation, shares what innovation means at AmerisourceBergen and how we are using our customer experience strategy to drive innovations like our new ordering platform, ABC Order.

With a significant number of obese and overweight adults in the United States, community pharmacists are poised to address the problem. Tips on how.

What manufacturers need to know about how distribution impacts access.

How drug manufacturers, health systems and payers can collaborate more closely in the new world of patient-centered care.

The growing trend toward value-based payment models and ongoing demand for clinical outcomes creates a need for better coordination of care. What challenges does this create for health system specialty pharmacies and what opportunities does this present for demonstrating value?

Matt Wolf, Group Vice President, Consulting Practice at Pharmacy Healthcare Solutions, shares how pharmacy can help the health system generate revenue and contain costs.

Insights from managed care executives on the future of coverage and outcomes evaluation.

Xcenda examines payer tactics for managing commercial copay assistance in a new issue brief.

Caregivers can depend on community pharmacies to provide the support and guidance needed to safeguard the health of their family members.

How hospitals and health systems are leveraging patient assistance programs to ease the financial burden of caring for under- and un-insured patients.

Claire Biermaas, Vice President, Customer Insight & Innovation, discusses AmerisourceBergen's unique approach to the customer experience.

Do you have the entrepreneurial spirit and drive to be a successful pharmacy owner? Here are some things you should know before you begin your journey.

Learn how one pharmacy successfully implemented a comprehensive smoking cessation program -- and how you can duplicate the results.

How medication adherence strategies are evolving to meet each individual’s unique needs.

Independent pharmacists share what it means to be independent and why independent pharmacy is worth protecting.

What role do community pharmacists play in patient trust, and how can pharmacies improve the patient experience to build trust?

How an innovative program efficiently and affordably connects patients with cutting-edge care and practices with elusive research opportunities

An effective unsaleable returns program can help independent pharmacies maximize the recoverable value of expired products and boost profitability.

How do manufacturers' distribution decisions ultimately impact patients? What long- and short-term disruption do direct models present? AmerisourceBergen experts offer perspective on the unintended consequences of channel strategy decisions.

An expert, data-driven evaluation can help provider practices deliver the high-quality, efficient care necessary for success in new reimbursement models.

Understanding the accreditation process can put pharmacies on the path to the gold standard for patient care.

Key healthcare and health policy trends to watch in 2018 -- and what they mean for pharmaceutical manufacturers.

Our strategic global sourcing experts share how AmerisourceBergen's leadership in specialty distribution influences the way we partner with manufacturers.

Planning ahead can help a community pharmacy owner maximize the value of their business for when he or she inevitably decides to retire or sell.

How inventory management solutions can help maximize operational and financial control in the ever-changing healthcare landscape.

Our experts share what customers wish manufacturers knew about product access.

How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?

Learn how immunizations present an opportunity for additional pharmacy revenue and enhanced patient care.

What manufacturers need to know about the customer experience.

What information do payers and providers want from pharma?

“We found a model that worked, and it has allowed us to grow rapidly. The impetus was to do what the bigger guys do, but better.”

U.S. biosimilars are coming, just as they’ve arrived and prospered in the Europe. By ensuring positive patient experiences, specialty pharmacies will help usher in a sustainable wave of biosimilar products.

Access to experienced coaches who offer innovative ideas for solving pharmacy challenges is the hallmark of Good Neighbor Pharmacy business coaching. Learn about some of the expert guidance a few of our business coaches have provided pharmacies.

Thinking about retirement? Explore five considerations to preserve the legacy of independent pharmacy for future generations.

Key themes from ThinkLive 2017, AmerisourceBergen's annual manufacturer summit.

Is your community pharmacy doing everything it can to gain and maintain patients through an online presence? Increase your community pharmacy’s digital footprint with these four tips.

Community pharmacists can improve adherence and outcomes by identifying health literacy issues and helping patients better understand their options.

Follow these unique tips to improve your community pharmacy’s business through the holiday season.

How a community pharmacy can stay ahead of the curve by leveraging advancements in technology.

How pharmaceutical wholesalers have evolved in recent years.

Specialty practices must take action today to prepare for full MACRA implementation.

Misconceptions about specialty pharmacy and the importance of meeting patients where they are in their healthcare journey.

By enhancing existing infrastructure and core assets with emerging technologies, pharmacy can be a driving force in an impactful population health management initiative.

Four key health system trends and the opportunities they present for pharmacy.

An industry expert explains how oncology practices are thriving by embracing innovation.

How an effective meds-to-beds program and robust data analytics can improve care continuity and lower readmissions for successful value-based care.

Take our quiz to find out what superpower lies behind the white coat.

Learn how community pharmacies can customize their marketing efforts and create stronger relationships with prescribers.

Everyone has a story. Learn how telling yours could help your practice thrive.

How can data-driven service design improve patient support programs and outcomes?

What should biosimilar manufacturers focus on for commercialization success?

What does the future of benefit verification look like for manufacturer patient support programs?

How are payers thinking about apps, wearables and other digital health technologies?

Understanding the unique considerations for reimbursement in the Canadian pharmaceutical market.

Three factors that could influence biosimilars' commercial success.

How strong is your community pharmacy’s financial picture?

How community pharmacies can use data-driven marketing to strengthen their relationships with prescribers, deliver better patient care and grow their businesses.

Tips for community pharmacies looking to keep inventory at the optimal level.

Four things to keep in mind for patient support partnerships.

Why it's crucial for veterinarians to create value in order to strengthen sales, productivity and client engagement.

Check out these tips for boosting customer satisfaction and retention by meeting and exceeding patient expectations.

Rich Tremonte on the current healthcare landscape, the role of the wholesaler and how the new organizational structure at AmerisourceBergen brings out the best in both.

Learn about the unique opportunities pharmacies have to lower drug costs, increase revenue and improve the patient experience.

Alternative methodologies for coding biosimilars reveal an addition $15.1 billion in hidden savings.

How community oncology practices can unlock the power of data for successful value-based care.

These key considerations can help veterinarians better understand the nature of the liability they're assuming when entering property leases.

The importance of cycle counts in providing an ongoing measure of inventory accuracy for high-value, high-movement items.

Eight ways to boost productivity, improve efficiency and ensure your community pharmacy runs like a well-oiled machine

What should manufacturers look for in a specialty pharmacy partner? Learn six ways the right SP can add value.

It's easy for employees to feel overwhelmed and distracted in a hectic community pharmacy. Here are six ways to help them stay engaged, motivated and focused.

In supply chain decisions, a wholly new type of product demands a wholly new definition for supply chain expertise and effective support.

Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.

Analytics is trending in transitional care, with impressive results for high-risk patients.

Five ways that oncology practices can optimize their operations and avoid financial strain.

Sam Herbert, President of World Courier, shares the factors that are driving trial sponsors to deploy innovative approaches to manage expenses and improve trial success.

A visualization of how pharmacists can help patients adhere to their medication regimens.

Learn the unintended consequences of channel strategy decisions and the impact on patients and providers.

Many community pharmacies want to employ a social media strategy but are overwhelmed and not sure where to begin. This how-to guide simplifies where to start.

How should manufacturers be using distribution data to uncover insights and manage access?

Explore what it means to put patients at the center of support program design through this interactive experience drawing perspective from real patients and how they view healthcare.

How pharmacy can drive revenue and standardization after a merger.

An interview with Matt George, patient advocate and survivor of paroxysmal nocturnal haemoglobinuria (PNH), a debilitating, rare and life-threatening disorder.

Pete Belden, President of ICS, shares how the manufacturer client base for 3PL is changing as a result of the rapid expansion of emerging manufacturers and industry consolidation.

Demonstrate the value of rare disease therapies with these five key ways to connect where patients, physicians and payers perceive the most value.

For a community pharmacy, maintaining customer loyalty is all about identifying and accentuating operational strengths. Here are some tips to help you succeed.

Expert perspectives on ways pharmacies can take control of their prescription reimbursement and ensure they are capturing maximum value.

New England Cancer Specialists demonstrates why staying the same simply isn't an option when it comes to cancer care. Learn how they adapted to the changing oncology landscape while putting patients first.

How community pharmacies can differentiate, grow and shine through retail excellence.

What opportunities does the shift to fee-for-value present for health system pharmacies?

Ways independent pharmacies can ensure their patients maintain their medication regimens.

A look at the trends and growth of cancer care alongside the critical considerations health systems need to weigh as they look to deliver the highest quality and most cost effective care in oncology.

Completing MTM cases can have a tremendous positive impact on the patient while delivering business value to the pharmacy. Learn more.

The five components manufacturers shouldn't ignore when building orphan drug support programs.

How pharmacies can take action now.

Tom Mullin, President of Community and Specialty Pharmacy at AmerisourceBergen, shares how pharmacies are using data to improve interactions with patients.

A look at the trends and growth of cancer care alongside the critical considerations health systems need to weigh as they look to deliver the highest quality.

What opportunities do ACOs present for health system pharmacies?

Like a slowly dripping faucet or an improperly insulated window, gaps and inefficiencies in a business allow profits to seep out over time. Even one leak—while seemingly small—can have damaging effects on a company’s financial health. Oncology practices are no different.

New England Cancer Specialists demonstrates why staying the same simply isn't an option when it comes to cancer care.

A pharmacy expert defines thresholds for medication adherence and outlines tools and programs to maximize patient adherence and pharmacy success.

How hospitals are accommodating more patient needs by transforming their care delivery models.

Six major drivers are changing how hospitals aim to improve the quality of care while controlling costs, but they're also potential opportunities for the health system pharmacy. This infographic explores exactly how those trends impact the pharmacy.

What does it really take to build, operate and evolve the health system’s ambulatory care model?

Leveraging data to get the total drug purchasing picture.

Does the C-Suite really know the value of ambulatory pharmacy?

New challenges to oncology product access, optimized clinical outcomes and commercial success, with strategic recommendations for how pharmaceutical manufacturers can support prescribers and patients through the continuum of cancer care.

Opportunities for pharmacies to spend more time caring for patients highlighted at ThoughtSpot 2016.

Medication synchronization, the process of coordinating all of a patient’s chronic medications to be filled at the same time each month, is the most valuable program for patients and staff I’ve ever implemented in my flagship store, Moundsville Pharmacy in Moundsville, West Virginia.

Designing support programs that are truly patient-centric and overcoming obstacles along the way.

How greater collaboration between oncologists and pharmacists can drive patient-centered solutions to improve adherence.

Precision medicine can improve patient outcomes and increase the effectiveness of therapy but physicians must still carefully navigate certain barriers.

MTM Program Completion Rate for Comprehensive Medication Reviews, a new process measure for 2016 within CMS’ Star Ratings, carries significance for independent pharmacies.

Mapping the patient journey and building support programs that address the three biggest hurdles patients face.

How can manufacturers turn patient-centricity from buzzword into reality?

Why the time is right for pharmacists to be recognized for the patient care that they provide.

The advantages of buying from one source.

How prepackaged unit dose medications can increase safety and efficiency while lowering risk and costs for America’s hospitals

How a strong medication reconciliation program can generate benefits that go far beyond safety.

Five questions to help you determine if your specialty distributor is really special.

As global manufacturers of specialty pharmaceuticals look to enter the Canadian market, it is important to understand the Canadian healthcare landscape with the provision of patient support services being an important consideration.

Why succession planning is essential.

A guide for oncology practices to improve patient adherence to oral oncolytics.

While health systems are finding significant benefits when it comes to offering the ambulatory pharmacy benefit, success depends on proper planning in three important areas.

How health systems can align their care delivery models with population health management goals.

Health systems implementing in-house, outpatient pharmacies as part of their strategy for addressing care transitions, are also leveraging the ambulatory pharmacy to improve their employee drug

Learn how health systems can drive outcomes with a specialty pharmacy strategy.

Successful commercialization demands that manufacturers address three critical areas of opportunity — evidence, access and adherence.

An executive Q&A on how Medication Therapy Management can impact Star Ratings.

The globalization of healthcare raises a number of questions for the pharmaceutical industry, from how R&D is changing to how to approach new markets.

How the Group Purchasing Organization (GPO) model has evolved — and what it means for manufacturers.